# Psyence Biomedical LTD.: Form 20-F for the period ended Mar 31, 2026

- Company: [Psyence Biomedical LTD.](/companies/pbm.md) (CIK 1985062)
- Form: 20-F
- Filed: 2026-06-22
- Accepted by EDGAR: Jun 22, 2026, 20:01 ET
- Period: 2026-03-31
- Accession: 0001213900-26-070607
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1985062/000121390026070607/ea0294983-20f_psyence.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1985062/000121390026070607/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2026-03-31 | 2,293,277 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1985062/000121390026070607/ea0294983-20f_psyence.htm

Filed Jun 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-070607. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.